Annual EBITDA
-$9.40 M
+$9.94 M+51.40%
December 31, 2023
Summary
- As of February 8, 2025, AMPE annual EBITDA is -$9.40 million, with the most recent change of +$9.94 million (+51.40%) on December 31, 2023.
- During the last 3 years, AMPE annual EBITDA has risen by +$5.26 million (+35.89%).
- AMPE annual EBITDA is now -939500.00% below its all-time high of -$1000.00, reached on December 31, 2006.
Performance
AMPE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.21 M
-$815.00 K-58.21%
December 31, 2023
Summary
- As of February 8, 2025, AMPE quarterly EBITDA is -$2.21 million, with the most recent change of -$815.00 thousand (-58.21%) on December 31, 2023.
- Over the past year, AMPE quarterly EBITDA has increased by +$303.00 thousand (+12.03%).
- AMPE quarterly EBITDA is now -738233.33% below its all-time high of -$300.00, reached on September 30, 2006.
Performance
AMPE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$9.40 M
+$303.00 K+3.12%
December 31, 2023
Summary
- As of February 8, 2025, AMPE TTM EBITDA is -$9.40 million, with the most recent change of +$303.00 thousand (+3.12%) on December 31, 2023.
- Over the past year, AMPE TTM EBITDA has increased by +$9.93 million (+51.38%).
- AMPE TTM EBITDA is now -3131900.00% below its all-time high of -$300.00, reached on September 30, 2006.
Performance
AMPE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AMPE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.4% | +12.0% | +51.4% |
| 3 y3 years | +35.9% | +38.8% | +35.9% |
| 5 y5 years | +5.1% | +0.4% | +45.7% |
AMPE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +51.8% | -58.2% | +75.3% | at high | +63.5% |
| 5 y | 5-year | at high | +51.8% | -58.2% | +75.3% | at high | +63.5% |
| alltime | all time | <-9999.0% | +69.8% | <-9999.0% | +78.8% | <-9999.0% | +74.0% |
Ampio Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$9.40 M(-51.4%) | -$2.21 M(+58.2%) | -$9.40 M(-3.1%) |
| Sep 2023 | - | -$1.40 M(-10.3%) | -$9.70 M(-29.1%) |
| Jun 2023 | - | -$1.56 M(-63.0%) | -$13.67 M(-18.8%) |
| Mar 2023 | - | -$4.22 M(+67.6%) | -$16.85 M(-12.8%) |
| Dec 2022 | -$19.33 M(-0.7%) | -$2.52 M(-53.2%) | -$19.33 M(-25.0%) |
| Sep 2022 | - | -$5.38 M(+13.6%) | -$25.77 M(+7.4%) |
| Jun 2022 | - | -$4.73 M(-29.4%) | -$23.99 M(+5.9%) |
| Mar 2022 | - | -$6.70 M(-25.2%) | -$22.65 M(+16.3%) |
| Dec 2021 | -$19.48 M(+32.9%) | -$8.96 M(+149.9%) | -$19.48 M(+37.8%) |
| Sep 2021 | - | -$3.59 M(+5.6%) | -$14.13 M(+4.3%) |
| Jun 2021 | - | -$3.40 M(-3.6%) | -$13.55 M(+8.8%) |
| Mar 2021 | - | -$3.52 M(-2.6%) | -$12.46 M(-15.0%) |
| Dec 2020 | -$14.66 M(-15.3%) | -$3.62 M(+20.3%) | -$14.66 M(-18.1%) |
| Sep 2020 | - | -$3.01 M(+30.6%) | -$17.89 M(-9.7%) |
| Jun 2020 | - | -$2.30 M(-59.8%) | -$19.81 M(-4.4%) |
| Mar 2020 | - | -$5.73 M(-16.4%) | -$20.72 M(+19.7%) |
| Dec 2019 | -$17.30 M(+74.7%) | -$6.85 M(+38.8%) | -$17.30 M(+36.5%) |
| Sep 2019 | - | -$4.93 M(+53.7%) | -$12.68 M(+35.8%) |
| Jun 2019 | - | -$3.21 M(+38.9%) | -$9.34 M(+4.5%) |
| Mar 2019 | - | -$2.31 M(+3.9%) | -$8.94 M(-9.7%) |
| Dec 2018 | -$9.90 M(-31.5%) | -$2.22 M(+39.6%) | -$9.90 M(-18.8%) |
| Sep 2018 | - | -$1.59 M(-43.3%) | -$12.19 M(-9.0%) |
| Jun 2018 | - | -$2.81 M(-14.1%) | -$13.40 M(-10.5%) |
| Mar 2018 | - | -$3.27 M(-27.4%) | -$14.97 M(+4.0%) |
| Dec 2017 | -$14.46 M(-8.9%) | -$4.51 M(+60.9%) | -$14.40 M(+14.8%) |
| Sep 2017 | - | -$2.80 M(-36.1%) | -$12.54 M(-1.9%) |
| Jun 2017 | - | -$4.39 M(+62.5%) | -$12.78 M(+2.6%) |
| Mar 2017 | - | -$2.70 M(+1.9%) | -$12.45 M(-21.5%) |
| Dec 2016 | -$15.87 M(-32.0%) | -$2.65 M(-12.8%) | -$15.87 M(-21.9%) |
| Sep 2016 | - | -$3.04 M(-25.2%) | -$20.31 M(-9.2%) |
| Jun 2016 | - | -$4.06 M(-33.6%) | -$22.36 M(-6.3%) |
| Mar 2016 | - | -$6.12 M(-13.7%) | -$23.87 M(+2.3%) |
| Dec 2015 | -$23.34 M | -$7.09 M(+39.1%) | -$23.34 M(+25.1%) |
| Sep 2015 | - | -$5.10 M(-8.6%) | -$18.66 M(-18.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | -$5.57 M(-0.2%) | -$22.93 M(-12.7%) |
| Mar 2015 | - | -$5.59 M(+132.4%) | -$26.26 M(-15.6%) |
| Dec 2014 | -$31.11 M(+30.2%) | -$2.40 M(-74.3%) | -$31.11 M(-14.1%) |
| Sep 2014 | - | -$9.37 M(+5.3%) | -$36.20 M(+10.6%) |
| Jun 2014 | - | -$8.90 M(-14.7%) | -$32.73 M(+8.2%) |
| Mar 2014 | - | -$10.43 M(+39.2%) | -$30.25 M(+26.0%) |
| Dec 2013 | -$23.89 M(+103.1%) | -$7.50 M(+27.0%) | -$24.01 M(+17.7%) |
| Sep 2013 | - | -$5.90 M(-8.0%) | -$20.40 M(+19.5%) |
| Jun 2013 | - | -$6.42 M(+53.2%) | -$17.07 M(+30.0%) |
| Mar 2013 | - | -$4.19 M(+7.7%) | -$13.13 M(+11.6%) |
| Dec 2012 | -$11.76 M(-35.5%) | -$3.89 M(+51.4%) | -$11.76 M(-2.3%) |
| Sep 2012 | - | -$2.57 M(+3.6%) | -$12.04 M(+0.8%) |
| Jun 2012 | - | -$2.48 M(-12.1%) | -$11.95 M(-2.8%) |
| Mar 2012 | - | -$2.82 M(-32.4%) | -$12.29 M(-32.6%) |
| Dec 2011 | -$18.23 M(+126.9%) | -$4.17 M(+68.3%) | -$18.24 M(+7.0%) |
| Sep 2011 | - | -$2.48 M(-12.1%) | -$17.05 M(+0.3%) |
| Jun 2011 | - | -$2.82 M(-67.9%) | -$17.00 M(+10.9%) |
| Mar 2011 | - | -$8.77 M(+194.5%) | -$15.33 M(+90.8%) |
| Dec 2010 | -$8.03 M(+431.9%) | -$2.98 M(+22.4%) | -$8.03 M(+42.4%) |
| Sep 2010 | - | -$2.43 M(+112.7%) | -$5.64 M(+51.5%) |
| Jun 2010 | - | -$1.14 M(-22.7%) | -$3.73 M(+24.6%) |
| Mar 2010 | - | -$1.48 M(+151.7%) | -$2.99 M(+97.9%) |
| Dec 2009 | -$1.51 M(+5072.6%) | -$587.50 K(+14.0%) | -$1.51 M(+62.9%) |
| Sep 2009 | - | -$515.20 K(+26.4%) | -$927.10 K(+121.6%) |
| Jun 2009 | - | -$407.70 K(+9607.1%) | -$418.30 K(+1327.6%) |
| Dec 2008 | -$29.20 K(-6.4%) | -$4200.00(-34.4%) | -$29.30 K(-12.8%) |
| Sep 2008 | - | -$6400.00(+137.0%) | -$33.60 K(-2.6%) |
| Jun 2008 | - | -$2700.00(-83.1%) | -$34.50 K(-26.4%) |
| Mar 2008 | - | -$16.00 K(+88.2%) | -$46.90 K(+50.3%) |
| Dec 2007 | -$31.20 K(+3020.0%) | -$8500.00(+16.4%) | -$31.20 K(+35.7%) |
| Sep 2007 | - | -$7300.00(-51.7%) | -$23.00 K(+43.8%) |
| Jun 2007 | - | -$15.10 K(+4933.3%) | -$16.00 K(+1677.8%) |
| Mar 2007 | - | -$300.00(0.0%) | -$900.00(+50.0%) |
| Dec 2006 | -$1000.00 | -$300.00(0.0%) | -$600.00(+100.0%) |
| Sep 2006 | - | -$300.00 | -$300.00 |
FAQ
- What is Ampio Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual EBITDA year-on-year change?
- What is Ampio Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Ampio Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals TTM EBITDA year-on-year change?
What is Ampio Pharmaceuticals annual EBITDA?
The current annual EBITDA of AMPE is -$9.40 M
What is the all time high annual EBITDA for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual EBITDA is -$1000.00
What is Ampio Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, AMPE annual EBITDA has changed by +$9.94 M (+51.40%)
What is Ampio Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of AMPE is -$2.21 M
What is the all time high quarterly EBITDA for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly EBITDA is -$300.00
What is Ampio Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, AMPE quarterly EBITDA has changed by +$303.00 K (+12.03%)
What is Ampio Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of AMPE is -$9.40 M
What is the all time high TTM EBITDA for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high TTM EBITDA is -$300.00
What is Ampio Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, AMPE TTM EBITDA has changed by +$9.93 M (+51.38%)